RT Journal Article
SR Electronic
T1 Dapagliflozin for type 1 diabetes: ensuring benefits outweigh the risks
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 34
OP 34
DO 10.1136/dtb.2019.000081
VO 58
IS 3
A1 David Erskine
YR 2020
UL http://dtb.bmj.com/content/58/3/34.abstract
AB